Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis

The use of immunobiological agents for the treatment of autoimmune diseases is increasing in medical practice. Anti-TNF therapies have been increasingly used in refractory autoimmune diseases, especially rheumatoid arthritis, with promising results. However, the use of such therapies has been associ...

Full description

Bibliographic Details
Published in:Jornal Brasileiro de Pneumologia
Main Authors: Olivia Meira Dias, Daniel Antunes Silva Pereira, Bruno Guedes Baldi, Andre Nathan Costa, Rodrigo Abensur Athanazio, Ronaldo Adib Kairalla, Carlos Roberto Ribeiro Carvalho
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2014-01-01
Subjects:
Doencas pulmonares intersticiais
Artrite reumatoide
Antirreumaticos
Anticorpos monoclonais humanizados/efeitos adversos
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132014000100077&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132014000100077&lng=en&tlng=en

Similar Items